|
🐜
|
Comparison of cardiovascular magnetic resonance feature tracking and tagging for the assessment of left ventricular systolic strain in acute myocardial infarction
7 auth.
J. Khan,
Anvesha Singh,
S. Nazir,
P. Kanagala,
J. Greenwood,
A. Gershlick,
...
G. Mccann
|
6 |
2015 |
6
🐜
|
|
🦁
|
Strategies to attenuate micro-vascular obstruction during P-PCI: the randomized reperfusion facilitated by local adjunctive therapy in ST-elevation myocardial infarction trial
13 auth.
S. Nazir,
G. Mccann,
J. Greenwood,
V. Kunadian,
J. Khan,
I. Mahmoud,
D. Blackman,
M. Been,
K. Abrams,
L. Shipley,
...
R. Wilcox,
A. Adgey,
A. Gershlick
|
6 |
2016 |
6
🦁
|
|
🐜
|
Intertechnique agreement and interstudy reproducibility of strain and diastolic strain rate at 1.5 and 3 tesla: A comparison of feature‐tracking and tagging in patients with aortic stenosis
10 auth.
Anvesha Singh,
C. Steadman,
J. Khan,
M. Horsfield,
Soliana Bekele,
S. Nazir,
...
P. Kanagala,
N. Masca,
P. Clarysse,
G. Mccann
|
6 |
2015 |
6
🐜
|
|
🐜
|
Complete Versus Lesion-Only Primary PCI
16 auth.
G. Mccann,
J. Khan,
J. Greenwood,
S. Nazir,
M. Dalby,
N. Curzen,
S. Hetherington,
D. Kelly,
D. Blackman,
A. Ring,
...
C. Peebles,
J. Wong,
T. Sasikaran,
M. Flather,
H. Swanton,
A. Gershlick
|
5 |
2015 |
5
🐜
|
|
🐜
|
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design.
19 auth.
D. Kelly,
G. Mccann,
D. Blackman,
N. Curzen,
M. Dalby,
J. Greenwood,
Kathryn L Fairbrother,
L. Shipley,
A. Kelion,
S. Heatherington,
...
J. Khan,
S. Nazir,
A. Alahmar,
M. Flather,
H. Swanton,
P. Schofield,
M. Gunning,
R. Hall,
A. Gershlick
|
5 |
2013 |
5
🐜
|
|
🦁
|
Endovascular Treatment Options in the Management of Lower Limb Deep Venous Thrombosis
S. Nazir,
A. Ganeshan,
S. Nazir,
R. Uberoi
|
5 |
2009 |
5
🦁
|
|
🐜
|
Infarct Size Following Treatment With Second‐ Versus Third‐Generation P2Y12 Antagonists in Patients With Multivessel Coronary Disease at ST‐Segment Elevation Myocardial Infarction in the CvLPRIT Study
15 auth.
J. Khan,
J. Greenwood,
S. Nazir,
F. Lai,
M. Dalby,
N. Curzen,
S. Hetherington,
D. Kelly,
D. Blackman,
C. Peebles,
...
J. Wong,
M. Flather,
H. Swanton,
A. Gershlick,
G. Mccann
|
5 |
2016 |
5
🐜
|
|
🐜
|
Comparison of semi-automated methods to quantify infarct size and area at risk by cardiovascular magnetic resonance imaging at 1.5T and 3.0T field strengths
8 auth.
J. Khan,
S. Nazir,
M. Horsfield,
Anvesha Singh,
P. Kanagala,
J. Greenwood,
...
A. Gershlick,
G. Mccann
|
5 |
2015 |
5
🐜
|
|
🐜
|
Prevalence and extent of infarct and microvascular obstruction following different reperfusion therapies in ST-elevation myocardial infarction
8 auth.
J. Khan,
N. Razvi,
S. Nazir,
Anvesha Singh,
N. Masca,
A. Gershlick,
...
I. Squire,
G. Mccann
|
4 |
2014 |
4
🐜
|
